A mother living with multiple sclerosis insists there should be more awareness of hidden disabilities so that people with ...
Abstract: The paper describes communication way between Multiple sclerosis's (MS) patient with Brain Computer Interface (BCI). In MS patient immunity system attacks the protective sheath that causes ...
CHICO, Calif. - October is Domestic Violence Awareness Month, and Catalyst is inviting the community to take action. The nonprofit is organizing a series of events throughout the month to honor ...
Methods: We generated 2160 synthetic datasets from two phase 3 RCTs in multiple sclerosis (NCT00213135 and NCT00906399; n = 865 and 1516 patients) with different configurations to select one synthetic ...
She was diagnosed with multiple sclerosis in 2018. Selma Blair, 53, is giving fans an update on her battle with the autoimmune disease. Speaking on “Today” on NBC, the “Cruel Intentions” actress from ...
The International Advisory Committee on Clinical Trials led a multinational panel updating the McDonald criteria, adding the optic nerve as a fifth anatomical location and allowing specific magnetic ...
Actor, author and advocate Selma Blair joins TODAY to talk about taking on new projects as she remains “relapse-free” for a couple years from multiple sclerosis. Blair opens up about embarking on new ...
Higher intake of ultra-processed foods (UPFs) may exacerbate disease activity in early multiple sclerosis (MS), according to new research presented at the 41st Congress of the European Committee for ...
Background Physical activity has been associated with neuroprotective and immunomodulatory benefits, potentially influencing long-term disability outcomes in multiple sclerosis (MS). However, ...
On Monday, the U.S. Food and Drug Administration (FDA) extended the review date for Sanofi SA’s (NASDAQ:SNY) new drug application (NDA) of tolebrutinib for non-relapsing, secondary progressive ...
Note: This story was updated Sept. 23, 2025, to correct the generic name of Aubagio from tolebrutinib to teriflunomide. The U.S. Food and Drug Administration (FDA) has delayed by three months its ...
bWeill Institute for Neurosciences, Department of Neurology, University of California, San Francisco, San Francisco, CA, USA cDepartment of Ophthalmology, University of California, San Francisco, San ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results